Kate Farms, a market leader in bringing plant-based nutrition into healthcare, has announced the completion of its Series C round of funding, led by Novo Holdings. Novo Holdings is among the world’s leading life science investors and is responsible for managing the assets of The Novo Nordisk Foundation. Additional participants in the up-round include current investors Kaiser Permanente Ventures, Goldman Sachs, Main Street Advisors, and existing individual investors. The Series C follows on the heels of the company’s successful Series B fund raise in 2020.
Latham & Watkins LLP represents Kate Farms in the financing with a Boston-based emerging companies team led by partners Evan Smith and John Chory, with associates Martha Anderson, Claire Bradford Di Caro, and Sally Gu.
Where the legal industry reads first.
Enjoyed this article? Get the biggest legal industry updates, deals, appointments, insights and expert interviews in your inbox, free.
No spam. Unsubscribe anytime.From Legal Desire
Is your firm the one being cited, or the one being skipped?
We ran the test. On several everyday legal questions, software companies are answering and law firms are not. We help firms fix that, and we build the technology behind the practice.
Lawyers and firms: get featured on Legal Desire
Share your deals, lateral moves, firm news and insights with 1M+ monthly readers: founders, law firm partners, general counsel and practising lawyers across the US, UK, EU and GCC.
Get featuredSubmit a press releaseThe advising firms, the named deal team, the value and the parties, with every other announced deal by the same firms and lawyers. Open the deal record
